Document is current
Any future updates will be listed below
-
Authors
Serrano-Pozo, Alberto https://orcid.org/0000-0003-0899-7530
Li, Huan https://orcid.org/0009-0007-7401-9715
Li, Zhaozhi
Muñoz-Castro, Clara https://orcid.org/0000-0002-4484-9802
Jaisa-aad, Methasit
Healey, Molly A.
Welikovitch, Lindsay A.
Jayakumar, Rojashree
Bryant, Annie G.
Noori, Ayush https://orcid.org/0000-0003-1420-1236
Connors, Theresa R.
Hu, Miwei
Zhao, Karen
Liao, Fan
Lin, Gen
Pastika, Timothy
Tamm, Joseph
Abdourahman, Aicha
Kwon, Taekyung
Bennett, Rachel E. https://orcid.org/0000-0001-9640-0575
Woodbury, Maya E.
Wachter, Astrid https://orcid.org/0009-0001-3977-7832
Talanian, Robert V.
Biber, Knut
Karran, Eric H.
Hyman, Bradley T. https://orcid.org/0000-0002-7959-9401
Das, Sudeshna https://orcid.org/0000-0002-9486-6811
-
Funding
Funding for this research was provided by:
Massachusetts Life Sciences Center (Neuroscience Consortium award, Neuroscience Consortium award, Neuroscience Consortium award, Neuroscience Consortium award)
Alzheimer’s Association (AACF-17-524184, AACF-17-524184-RAPID)
- License Information
-
More Information
Article History
Received: 11 November 2022
Accepted: 17 September 2024
First Online: 11 November 2024
Competing interests
: M.E.W., A.W., K.Z., F.L., G.L., T.P., J.T., A.A., T.K., R.V.T, K.B. and E.H.K. are employees of Abbvie. The design, study conduct and financial support for this research were provided by Abbvie. Abbvie participated in the interpretation of data, review and approval of the publication. B.T.H. has a family member who works at Novartis and owns stock in Novartis, serves on the scientific advisory board of Dewpoint and owns stock, serves on a scientific advisory board or is a consultant for Abbvie, Arvinas, Biogen, Novartis, Cell Signaling Technologies, Sangamo, Sanofi, Takeda, US Department of Justice and Vigil, and his laboratory is supported by sponsored research agreements with Abbvie, F Prime and Spark. The remaining authors declare no competing interests.
